X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (55) 55
humans (46) 46
oncology (45) 45
female (36) 36
article (35) 35
breast cancer (32) 32
breast neoplasms - genetics (19) 19
breast neoplasms - pathology (19) 19
breast neoplasms - drug therapy (18) 18
cell biology (17) 17
cell line, tumor (16) 16
mutation (16) 16
trastuzumab (16) 16
animals (14) 14
mice (14) 14
cancer (13) 13
her2 (13) 13
skin and connective tissue diseases (13) 13
receptor, erbb-2 - metabolism (11) 11
tumors (11) 11
adult (10) 10
breast neoplasms - metabolism (10) 10
metastasis (10) 10
middle aged (10) 10
signal transduction (10) 10
therapy (10) 10
mice, nude (9) 9
neoplasms (9) 9
phosphatidylinositol 3-kinases - genetics (9) 9
resistance (9) 9
aged (8) 8
breast-cancer (8) 8
expression (8) 8
ligands (8) 8
mutations (8) 8
pathway (8) 8
proto-oncogene proteins c-akt - metabolism (8) 8
survival (8) 8
activation (7) 7
amplification (7) 7
drug resistance, neoplasm - genetics (7) 7
estrogen (7) 7
estrogen receptor alpha - genetics (7) 7
genetic aspects (7) 7
growth (7) 7
inhibitor (7) 7
neoplasm metastasis (7) 7
phosphatidylinositol 3-kinases - metabolism (7) 7
phosphorylation (7) 7
protein kinase inhibitors - pharmacology (7) 7
receptor, erbb-2 - genetics (7) 7
akt (6) 6
antineoplastic agents - therapeutic use (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
biochemistry & molecular biology (6) 6
breast (6) 6
cancer research (6) 6
cells (6) 6
estrogen receptors (6) 6
hsp90 heat-shock proteins - antagonists & inhibitors (6) 6
inhibition (6) 6
mcf-7 cells (6) 6
tamoxifen (6) 6
xenograft model antitumor assays (6) 6
alpha (5) 5
breast neoplasms - mortality (5) 5
class i phosphatidylinositol 3-kinases (5) 5
disease-free survival (5) 5
dna mutational analysis (5) 5
drug resistance (5) 5
fulvestrant (5) 5
kinase (5) 5
male (5) 5
metastases (5) 5
neoplasms - drug therapy (5) 5
neoplasms - genetics (5) 5
phosphatidylinositol 3-kinases - antagonists & inhibitors (5) 5
proto-oncogene proteins c-akt - antagonists & inhibitors (5) 5
receptors, estrogen - metabolism (5) 5
research article (5) 5
signal transduction - drug effects (5) 5
treatment outcome (5) 5
american society (4) 4
antibodies, monoclonal, humanized (4) 4
breast neoplasms - enzymology (4) 4
cancer therapies (4) 4
chemotherapy (4) 4
development and progression (4) 4
epidermal growth factor (4) 4
gene expression (4) 4
genes, erbb-2 (4) 4
genetics & heredity (4) 4
health aspects (4) 4
immunohistochemistry (4) 4
lapatinib (4) 4
lung-cancer (4) 4
medical research (4) 4
metastatic breast-cancer (4) 4
neoplasms - metabolism (4) 4
neoplasms - pathology (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Discovery, ISSN 2159-8274, 04/2012, Volume 2, Issue 4, pp. 311 - 319
Mutational activation of growth factor signaling pathways is commonly observed and often necessary for oncogenic transformation. Under physiologic conditions,... 
MAMMALIAN TARGET | BREAST-CANCER | RAPAMYCIN | INSULIN | ACTIVATION | INHIBITION | ONCOLOGY | PATHWAY | SIGNALING NETWORK | KINASE | AKT | Neoplasms - metabolism | Drug Resistance, Neoplasm | Signal Transduction | Molecular Targeted Therapy | Humans | Neoplasms - drug therapy
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 2014, Volume 20, Issue 6, pp. 1410 - 1416
The HER family of receptor tyrosine kinases, including EGF receptor (EGFR), HER2, HER3, and HER4, transduce growth-promoting signals in response to ligand... 
BREAST-CANCER | LUNG | ACTIVATION | INHIBITION | ERBB3 | ONCOLOGY | PHOSPHATIDYLINOSITOL 3-KINASE | SOMATIC MUTATION | UP-REGULATION | KINASE DOMAIN | FAMILY | Neoplasms - metabolism | Receptor, ErbB-3 - metabolism | Animals | Neoplasms - genetics | Humans | Receptor, ErbB-3 - genetics | Molecular Targeted Therapy
Journal Article
Nature Genetics, ISSN 1061-4036, 12/2013, Volume 45, Issue 12, pp. 1439 - 1445
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2019, Volume 37, Issue 14, pp. 1148 - 1148
Journal Article
Cancer Cell, ISSN 1535-6108, 2011, Volume 19, Issue 1, pp. 58 - 71
Activation of the PI3K-AKT pathway in tumors is modulated by negative feedback, including mTORC1-mediated inhibition of upstream signaling. We now show that... 
RAPAMYCIN | TARGET | FORKHEAD TRANSCRIPTION FACTOR | CELLS | INSULIN-RECEPTOR | ACTIVATION | ONCOLOGY | SIGNALING PATHWAY | PHOSPHORYLATION | UPSTREAM | HUMAN CANCER | CELL BIOLOGY | RNA, Small Interfering - genetics | Receptor, IGF Type 1 - metabolism | Protein Binding - genetics | Receptor, ErbB-3 - metabolism | Humans | Forkhead Transcription Factors - metabolism | Protein Binding - drug effects | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Receptor, ErbB-2 - antagonists & inhibitors | Phosphorylation - drug effects | Proto-Oncogene Proteins c-akt - metabolism | Quinoxalines - therapeutic use | Carcinoma, Non-Small-Cell Lung - metabolism | Receptor, ErbB-3 - genetics | Receptor Protein-Tyrosine Kinases - metabolism | Breast Neoplasms - drug therapy | Receptor, IGF Type 1 - genetics | Signal Transduction - drug effects | Mice, Nude | Models, Biological | Cell Line, Tumor | Mice | TOR Serine-Threonine Kinases | Feedback, Physiological - physiology | Quinazolines - pharmacology | Proteins - antagonists & inhibitors | Neoplasms - metabolism | Gene Expression - drug effects | Multiprotein Complexes | Receptor, ErbB-2 - metabolism | Promoter Regions, Genetic - genetics | Proto-Oncogene Proteins c-akt - genetics | Breast Neoplasms - metabolism | Mechanistic Target of Rapamycin Complex 1 | Quinoxalines - pharmacology | Receptor, Insulin - genetics | Female | Forkhead Transcription Factors - antagonists & inhibitors | Gene Expression Regulation, Neoplastic - drug effects | Drug Therapy, Combination | Gene Expression Regulation, Neoplastic - physiology | Carcinoma, Non-Small-Cell Lung - pathology | Up-Regulation - genetics | Forkhead Transcription Factors - genetics | Xenograft Model Antitumor Assays | Animals | Receptor Protein-Tyrosine Kinases - genetics | Breast Neoplasms - pathology | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Feedback, Physiological - drug effects | Receptor, Insulin - metabolism | Signal Transduction - physiology | Protein Kinase Inhibitors - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Benzylamines - pharmacology | Benzylamines - therapeutic use | Proto-Oncogene Proteins c-akt - antagonists & inhibitors
Journal Article
Journal Article
British Journal of Cancer, ISSN 0007-0920, 03/2017, Volume 116, Issue 6, pp. 726 - 730
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 3/2011, Volume 108, Issue 9, pp. 3761 - 3766
Journal Article
Cancer Cell, ISSN 1535-6108, 2011, Volume 19, Issue 5, pp. 575 - 586
Prostate cancer is characterized by its dependence on androgen receptor (AR) and frequent activation of PI3K signaling. We find that AR transcriptional output... 
TARGET | CELLS | ONCOLOGY | PATHWAY | DUAL PI3K/MTOR INHIBITOR | KINASE | TUMOR-SUPPRESSOR | AKT | INDUCTION | MTOR COMPLEX | HORMONAL-THERAPY | CELL BIOLOGY | Receptor, ErbB-3 - metabolism | Phosphatidylinositol 3-Kinase - antagonists & inhibitors | Humans | Phosphoprotein Phosphatases - metabolism | Receptors, Androgen - metabolism | Gene Expression Regulation, Neoplastic | Receptor, ErbB-2 - metabolism | Male | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Prostatic Neoplasms - genetics | Receptors, Androgen - drug effects | Transfection | RNA Interference | Time Factors | Transcription, Genetic | Receptor, ErbB-2 - antagonists & inhibitors | Proto-Oncogene Proteins c-akt - metabolism | Phosphatidylinositol 3-Kinase - metabolism | Genes, Reporter | Prostatic Neoplasms - drug therapy | PTEN Phosphohydrolase - genetics | Prostatic Neoplasms - pathology | PTEN Phosphohydrolase - deficiency | Androgen Antagonists - pharmacology | Receptor, ErbB-3 - antagonists & inhibitors | Mice, Transgenic | Nuclear Proteins - metabolism | Mice, SCID | Proto-Oncogene Proteins c-myc - metabolism | Mice, Knockout | Xenograft Model Antitumor Assays | Magnetic Resonance Imaging | Feedback, Physiological | Animals | Signal Transduction - drug effects | Tumor Burden - drug effects | Cell Line, Tumor | Prostatic Neoplasms - enzymology | Cell Proliferation - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Proto-Oncogene Proteins c-myc - genetics | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Phosphatases | Health aspects | Phosphotransferases | Prostate cancer | Analysis | Tumors
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2014, Volume 32, Issue 19, pp. 2078 - 2099
Journal Article